NCT03126682View on ClinicalTrials.gov

Effect of Bupropion on Seizure Threshold in Depressed Patients

PHASE4CompletedINTERVENTIONAL

Enrollment

10

Participants

Timeline

Start Date

August 25, 2017

Primary Completion Date

May 31, 2018

Study Completion Date

May 31, 2018

Conditions

MDD

Interventions

DRUG

Wellbutrin SR 300Mg Extended-Release Tablet

Wellbutrin SR 300Mg Extended-Release Tablet

Trial Locations (1)

27710

Duke University Medical Center, Durham

Sponsors

Lead Sponsor

Duke University

All Listed Sponsors

lead

Duke University

OTHER

NCT03126682 - Effect of Bupropion on Seizure Threshold in Depressed Patients | Biotech Hunter | Biotech Hunter